middle.news
How Did Artrya Secure FDA’s Green Light for Salix Coronary Flow?
10:11am on Friday 10th of October, 2025 AEDT
•
Healthcare
Read Story
How Did Artrya Secure FDA’s Green Light for Salix Coronary Flow?
10:11am on Friday 10th of October, 2025 AEDT
Key Points
FDA confirms 510(k) as regulatory route for Salix Coronary Flow
Q-Submission meeting provides detailed FDA feedback
Artrya to update study design and application accordingly
Final 510(k) submission targeted by end of 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE